key: cord-0766565-vmj6sb69
authors: Wang, Zhong‐hua; Fu, Bing‐qi; Lin, Ying‐wen; Wei, Xue‐biao; Geng, Heng; Guo, Wei‐xin; Yuan, Hui‐qing; Liao, You‐wan; Qin, Tie‐he; Li, Fei; Wang, Shou‐hong
title: Red blood cell distribution width: A severity indicator in patients with COVID‐19
date: 2022-01-31
journal: J Med Virol
DOI: 10.1002/jmv.27602
sha: ccdd37596a9d69d66769099a97c4745f899d0fac
doc_id: 766565
cord_uid: vmj6sb69

Red blood cell distribution width (RDW) was frequently assessed in COVID‐19 infection and reported to be associated with adverse outcomes. However, there was no consensus regarding the optimal cutoff value for RDW. Records of 98 patients with COVID‐19 from the First People's Hospital of Jingzhou were reviewed. They were divided into two groups according to the cutoff value for RDW on admission by receiver operator characteristic curve analysis: ≤11.5% (n = 50) and >11.5% (n = 48). The association of RDW with the severity and outcomes of COVID‐19 was analyzed. The receiver operating characteristic curve indicated that the RDW was a good discrimination factor for identifying COVID‐19 severity (area under the curve = 0.728, 95% CI: 0.626–0.830, p < 0.001). Patients with RDW > 11.5% more frequently suffered from critical COVID‐19 than those with RDW ≤ 11.5% (62.5% vs. 26.0%, p < 0.001). Multivariate logistic regression analysis showed RDW to be an independent predictor for critical illness due to COVID‐19 (OR = 2.40, 95% CI: 1.27−4.55, p = 0.007). A similar result was obtained when we included RDW > 11.5% into another model instead of RDW as a continuous variable (OR = 5.41, 95% CI: 1.53−19.10, p = 0.009). RDW, as an inexpensive and routinely measured parameter, showed promise as a predictor for critical illness in patients with COVID‐19 infection. RDW > 11.5% could be the optimal cutoff to discriminate critical COVID‐19 infection.

infection. RDW > 11.5% could be the optimal cutoff to discriminate critical COVID-19 infection. 19) , a pandemic that has affected more than 4 500 000 individuals and caused nearly 300 000 deaths worldwide as of mid-May 2020. It has been reported that 14% of patients with COVID-19 had severe disease, of which 5% progressed to critically ill with multiorgan failure, and the mortality rate in the critically ill group was 49%. 1 Moreover, the duration from the development of initial symptoms to the onset of critical illness is 10 days. 2 The delayed onset of critical illness in patients with COVID-19 and high mortality rate among them emphasize the importance of identifying an early predictive biomarker.

Red blood cell distribution width (RDW) is a routinely measured laboratory parameter that reflects the variation of red blood cell (RBC) volume. 3 RDW is influenced by imbalanced physiological conditions, including oxidative stress, tissue hypoxia, neuro-humoral over-activity, endothelial dysfunction, and inflammation status, which plays an important role in COVID-19 infection. 4, 5 Clinically, elevated RDW has been demonstrated to be associated with adverse outcomes in several clinical conditions, 3,6,7 including COVID-19 infection. 8, 9 Nevertheless, the optimal cut-off value for RDW in predicting adverse outcomes in COVID-19 was inconsistent among studies. 9 Therefore, we conducted the present study to further investigate the relationship between RDW and COVID-19 severity, and to explore the optimal cut-off value for RDW.

Patients older than 18 years old that were admitted at the First People's Hospital of Jingzhou from January 2020 to March 2020, and with a laboratory-confirmed diagnosis of COVID-19 infection were consecutively included. A laboratory-confirmed diagnosis of COVID-19 was determined by a positive result on a reversetranscriptase polymerase chain reaction assay of a specimen collected on a nasopharyngeal swab according to the WHO interim guideline. 10 Patients lacking laboratory results on RDW were excluded. The study was approved by the Ethics Committee of the First People's Hospital of Jingzhou, with a waiver of informed consent because of the urgency of the epidemic (L20200208). All blood samples were collected routinely on admission and analyzed within 4 h of collection. The CBC with differential, including RDW, was performed using an Automated Hematology Analyzer (sx500i, sx2800 and sx9000; Sysmex Corporation).

The degree of severity of COVID-19 was defined during hospitalization based on the fifth version of the National Health Commission Guideline on the Management of Novel Coronavirus Pneumonia. Critical COVID-19 was defined by one of the following criteria: indication of respiratory failure or mechanical ventilation, shock, and organ dysfunction requiring ICU admission. Anemia was defined as hemoglobin level <120 g/L in men and <110 g/L in women.

Statistical analyses were undertaken using SPSS 24.0 (IBM). Continuous variables are expressed as the mean ± standard deviation (SD), median values, interquartile ranges, or simple ranges. Categorical variables are summarized as counts and percentages. Continuous data with a normal distribution were compared using the Student's t test. Data with a nonnormal distribution were compared using the Wilcoxon rank-sum test and presented as the median and interquartile range. Categorical data were compared using the χ 2 test or Fisher's exact test. Receiver operator characteristic (ROC) curve analysis was performed to evaluate the predictive value of RDW for critical COVID-19. In addition, the optimal cutoff value was calculated via Youden's J statistic, which is the result of highest sensitivity and specificity. The optimal cutoff value was the point that the Youden function reaches its maximum value.

Univariate logistic regression analysis was conducted to assess the risk factors for critical COVID-19, and the indicators with pvalue < 0.05 were entered into a multivariate logistic regression for further analysis.

p < 0.05 was considered significant.

A total of 98 patients with laboratory-confirmed COVID-19 were included in this study. The mean age was 56 ± 17 years, 48 (49.0%) patients were male, and 43 (43.9%) patients suffered from critical COVID-19. An ROC curve analysis was conducted to determine the predictive value of RDW on admission for COVID-19 severity. The optimal cutoff value was 11.5%, with relatively high sensitivity and specificity (area under the curve = 0.728, 95% confidence interval (CI): 0.626-0.830, p < 0.001, Figure 1 ).

The subjects were classified into two groups according to the cutoff of RDW ≤ 11.5% (n = 50) and >11.5% (n = 48). Clinical information was compared between the two groups ( Although the underlying pathophysiological mechanism of these strong associations remains unclear, several explanations may account for this phenomenon. Increased RDW may reflect overall inflammatory status, oxidative stress, or arterial underfilling. 3 Anemia was a common finding in patients with COVID-19. Prevalence of anemia was significantly higher in patients who died from COVID-19 than survivors. 2 In our univariate analysis, anemia was also a risk factor for COVID-19 severity. In addition, hemoglobin level was found to be negatively correlated with RDW. However, in the multivariate analysis, RDW was an independent predictor for COVID-19 severity even after adjusting anemia, indicating other potential explanations for this effect.

Accumulating evidence suggested that patients with severe COVID-19 might have hyperinflammatory status with a cytokine storm. 4, 23 Systemic inflammation accompanied by cytokine release has a negative impact on bone marrow function and iron metabolism, and inflammatory cytokines suppress erythrocyte maturation, accentuated with sepsis, allowing newer, larger reticulocytes to enter the circulation, which is associated with RDW increase. [24] [25] [26] [27] The role of oxidative stress during infection is not fully elucidated, but free radicals have been shown to protect against invading microorganisms. 28 Reactive oxygen species such as nitrate oxide (NO), peroxynitrite, and superoxide radicals have been associated with endothelial damage. 29 Pathological findings in patients with COVID-19 supported the presence of endothelial cell damage and endotheliitis possibly due to direct viral infection and diffuse endothelial inflammation. 30 Oxidative stress could directly damage RBCs and decrease their survival, which might lead to anisocytosis and increased RDW. [31] [32] [33] Furthermore, selenium, as a component of the antioxidant defense system, was negatively correlated with RDW. 34 Higher RDW might reflect severe oxidative stress.

Finally, elevated RDW was found to be associated with activation of the renin−angiotensin−aldosterone system (RAAS). 35 Angiotensin-converting enzyme 2 (ACE2), an enzyme that physiologically counters RAAS activation, is the functional receptor for SARS-CoV-2. Furthermore, SARS-CoV-2 not only enters through ACE2 but also subsequently downregulates ACE2 expression such that the enzyme is unable to exert protective effects in organs. 36 

Among patients with COVID-19 infection, RDW, as a simple, inexpensive, and routinely measured laboratory parameter, was independently associated with disease severity. RDW > 11.5% could be the optimal cutoff to discriminate critical COVID-19 infection and might be helpful in clinical practice to identify critical cases at an early stage. Future studies should focus on elucidating the underlying mechanism of this association.

This study was supported by grants from the Project of Administration of Traditional Chinese Medicine of Guangdong Province of China (20211001). The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.

The authors declare that there are no conflict of interests.

Shou-hong Wang, Heng Geng, and Tie-he Qin contributed to the conception and design of the study. Zhong-hua Wang, Bing-qi Fu,

Ying-wen Lin, Xue-biao Wei, Fei Li, Wei-xin Guo, Hui-qing Yuan, Youwan Liao contributed to the acquisition, analysis, and interpretation of data. Zhong-hua Wang, Bing-qi Fu, and Ying-wen Lin drafted the manuscript. All authors critically revised the manuscript and gave final approval for publication.

The data underlying this article cannot be shared publicly due to the privacy of individuals that participated in the study. The data will be shared at reasonable request to the corresponding author.

Shou-hong Wang http://orcid.org/0000-0001-8937-5201

Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Red blood cell distribution width: a simple parameter with multiple clinical applications

COVID-19: consider cytokine storm syndromes and immunosuppression

Comparative evaluation of red blood cell distribution width and high sensitivity C-reactive protein in predicting all-cause mortality and coronary heart disease mortality

Red blood cell distribution width predicts long-term outcomes in sepsis patients admitted to the intensive care unit

Red blood cell distribution width and mortality and hospitalizations in peritoneal dialysis patients

Association between red blood cell distribution width and mortality and severity among patients with COVID-19: a systematic review and meta-analysis

Role of red blood cell distribution width, as a prognostic indicator in COVID-19: a systematic review and meta-analysis

Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance. World Health Organization

Red cell distribution width predicts out of hospital outcomes in critically ill emergency general surgery patients

Red cell distribution width (RDW) as a biomarker for respiratory failure in a pediatric ICU

Red cell distribution width and all-cause mortality in critically ill patients

A tool for early prediction of severe coronavirus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China

Red blood cell distribution width (RDW) predicts COVID-19 severity: a prospective, observational study from the Cincinnati SARS-CoV-2 Emergency Department Cohort

Association of red blood cell distribution width with mortality risk in hospitalized adults with SARS-CoV-2 infection

Increased red cell distribution width is associated with disease severity in hospitalized adults with SARS-CoV-2 infection: an observational multicentric study

Red cell distribution width upon hospital admission predicts short-term mortality in hospitalized patients with COVID-19: a single-center experience

Association between red blood cell distribution width and mortality of COVID-19 patients

Evaluating red blood cell distribution width from community blood tests as a predictor of hospitalization and mortality in adults with SARS-CoV-2: a cohort study

Red cell distribution width (RDW): a prognostic indicator of severe COVID-19

Simple parameters from complete blood count predict in-hospital mortality in COVID-19

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)

Erythropoietin response is blunted in critically ill patients

Influence of acute inflammation on iron and nutritional status indexes in older inpatients

Anemia of chronic disease

Role of oxidative stress in infectious diseases. A review

Oxygen radicals, nitric oxide, and peroxynitrite: redox pathways in molecular medicine

Endothelial cell infection and endotheliitis in COVID-19

Oxidation and erythrocyte senescence

SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness

Oxidative stress in the regulation of normal and neoplastic hematopoiesis

Serum antioxidants and inflammation predict red cell distribution width in older women: the Women's Health and Aging Study I

Enhanced erythropoiesis mediated by activation of the renin−angiotensin system via angiotensin II type 1a receptor

Renin−angiotensin−aldosterone system inhibitors in patients with Covid-19

Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics

Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury

Red blood cell distribution width: a severity indicator in patients with COVID-19